loading

Nachrichten werden geladen...

News zu #cancer

Benjamin Schumann (right) with his team at the Crick Institute. Today he is Professor of Biochemistry at the TU Dresden.  © PR/Michael Bowles

Sweet signals decoded: Biochemists track cell communication

How do cells talk to each other? A team at TU Dresden has succeeded in making the most important sensors on the cell surface visible for the first time. The so-called proteoglycans receive signals and control how cells grow and react. The new method could help to better understand cancer and develop new therapies in the future.

Johanna Trommer and Tobias Krönke are part of the HZDR team that developed the special molecular marker.  © HZDR/K.Zheynova

New marker shows which bladder cancer patients benefit from therapy

Researchers at the Helmholtz-Zentrum Dresden-Rossendorf have developed a molecular marker to help doctors choose the right bladder cancer therapy. The radiotracer NECT-224 makes visible whether tumors carry a certain protein to which modern drugs can dock. In summer 2025, it was used successfully for the first time on a patient at Dresden University Hospital.